Centenial Surgical Suture Ltd531380Corporate

Medical Equipment & Supplies Latest results: Jun 2026 14 quarters of data

₹97.05

MCap ₹27 Cr

Centenial Surgical Suture Ltd — Stock analysis & AI research Centenial Surgical Suture Ltd — Live exchange announcements

AI-assisted data: figures and text on this page are extracted from public quarterly filings with AI assistance, checked automatically and overseen by our editorial team (human in the loop). They may still contain errors or omissions. Verify critical numbers against official company / SEBI / NSE / BSE filings before making any decision. Educational information only, not financial advice.

₹15 Cr

Sales · Jun 2026

+18.6% YoY

₹2 Cr

Operating Profit · Jun 2026

+77.3% YoY

14.2%

OPM % · Jun 2026

+49.5% YoY

₹1 Cr

Net Profit · Jun 2026

+1937.8% YoY

₹2.01

EPS · Jun 2026

+1927.3% YoY

📝 Centenial Surgical Suture Ltd — results explained

Quarter ended June 2026 (Q1 FY27)

Centenial Surgical Suture Ltd reported revenue of ₹15 crore for the quarter ended June 2026 (Q1 FY27), up 18.6% from ₹13 crore in the same quarter last year, and up 22.0% sequentially over the March 2026 quarter.

The company swung to a net profit of ₹1 crore from a net loss of ₹0 crore a year earlier. Earnings per share (EPS) came in at ₹2.01.

Operating profit stood at ₹2 crore — an operating margin (OPM) of 14.2%, compared with 9.5% in the year-ago quarter.

Full year and trailing twelve months

For the full year FY26, Centenial Surgical Suture Ltd posted revenue of ₹54 crore, a growth of 0.6% over FY25, with a net loss of ₹2 crore.

On a trailing-twelve-month (TTM) basis, revenue stands at ₹56 crore with a net loss of ₹1 crore.

Valuation snapshot

At the current price of ₹97.05, 531380 has a market capitalisation of ₹27 crore.

Within the Medical Equipment & Supplies industry, it is the 12th-largest of the 13 companies we track by market value.

Shareholding pattern

As of Jun 2026, promoters held 46.89%, public shareholders 53.11% of Centenial Surgical Suture Ltd.

📈 Share price & events

📊 Quarterly trend

₹ crore · OPM % on right axis

🎯 Key metrics

price-linked ratios use the latest close

Valuation

Market Cap ?

₹27 Cr

Current Price ?

₹97.0

P/E ?

N/A

Industry P/E ?

26.90

P/B ?

0.96

P/S ?

0.49

P/FCF ?

5.41

Enterprise Value ?

₹38 Cr

EV/EBITDA ?

6.31

PEG ?

N/A

Earnings Yield ?

5.4%

Dividend Yield ?

0.00%

Profitability & Returns

Sales (TTM) ?

₹56 Cr

OPM ?

10.7%

Profit after tax (TTM) ?

₹-1 Cr

EPS (TTM) ?

₹-5.10

ROCE ?

2.5%

ROE ?

-5.0%

ROA ?

-1.8%

Growth

Sales — latest qtr ?

₹15 Cr

PAT — latest qtr ?

₹1 Cr

YoY qtr sales growth ?

18.6%

YoY qtr profit growth ?

1,937.8%

Sales growth (3y) ?

Sales growth (5y) ?

Profit growth (3y) ?

N/A

Profit growth (5y) ?

N/A

Financial Health

Debt ?

₹11 Cr

Debt to Equity ?

0.38

Interest Coverage ?

0.3

Current Ratio ?

N/A

Ownership

Promoter holding ?

46.89%

Change in promoter holding ?

0.00%

Pledged percentage ?

N/A

Market

Return 3 months ?

32.9%

Return 6 months ?

11.6%

🗓️ Quarterly results (14 quarters · ₹ Cr)

same fiscal quarter as Jun bestweakest per row · for costs (interest, NPAs) low is best Highlight

Metric	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	YoY %	QoQ %
Sales	13	14	13	12	12	14	14	12	13	13	13	15	13	15	+18.6%	+22.0%
Operating Profit	1	1	1	1	2	2	2	1	2	1	1	2	1	2	+77.3%	+134.5%
Other Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0	—	-84.0%
Interest	1	0	1	1	1	1	1	0	2	0	0	0	2	0	-9.5%	-86.9%
Depreciation	0	0	0	0	0	1	1	1	1	1	1	1	1	1	-3.2%	-9.8%
Profit Before Tax	0	0	0	0	0	0	0	-1	-1	-0	-0	0	-2	1	+2555.7%	+144.0%
Net Profit	0	0	0	0	0	0	0	-1	-1	-0	-0	0	-2	1	+1937.8%	+131.8%
EPS	0.38	0.79	0.66	0.85	0.52	0.82	0.36	-2.33	-3.23	-0.11	-0.03	0.41	-6.33	2.01	+1927.3%	+131.8%
OPM %	8.4%	8.5%	8.7%	9.6%	12.5%	12.5%	12.1%	6.1%	15.5%	9.5%	10.3%	10.3%	7.4%	14.2%	+49.5%	+91.9%

📆 Annual results (₹ Cr, FY = Apr–Mar)

Metric	FY25	FY26	TTM	YoY %
Sales	₹54 Cr	₹54 Cr	₹56 Cr	+0.6%
Operating Profit	₹6 Cr	₹5 Cr	₹6 Cr	-18.8%
OPM %	11.70%	9.44%	10.72%	-19.3%
NPM %	-2.99%	-4.10%	-2.55%	-37.1%
Other Income	₹0 Cr	₹0 Cr	₹0 Cr	+41.7%
Depreciation	₹4 Cr	₹4 Cr	₹4 Cr	-5.9%
Interest	₹4 Cr	₹3 Cr	₹3 Cr	-10.9%
EBIT	₹2 Cr	₹1 Cr	₹2 Cr	-46.3%
PBT	₹-2 Cr	₹-2 Cr	₹-1 Cr	-29.0%
Tax	—	—	₹0 Cr	—
Net Profit	₹-2 Cr	₹-2 Cr	₹-1 Cr	-38.1%
EPS	₹-4.38	₹-6.06	₹-3.94	-38.4%
Material Cost	—	—	₹4 Cr	—
Employee Cost	—	—	₹3 Cr	—
Extraordinary Items	—	—	—	—

🏛️ Balance Sheet (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Equity Capital	5.42	5.42	5.42	5.42	+0.0%
Reserves	25.66	26.79	25.33	23.13	-8.7%
Borrowings	9.92	23.24	30.01	10.71	-64.3%
Other Liabilities	25.40	23.70	23.83	40.53	+70.1%
Total Liabilities	66.40	79.15	84.59	79.79	-5.7%
Fixed Assets	6.46	12.77	19.99	18.22	-8.9%
CWIP	0.00	0.00	0.00	0.00	—
Investments	0.00	0.00	0.00	0.00	—
Other Assets	59.94	66.38	64.60	61.57	-4.7%
Total Assets	66.40	79.15	84.59	79.79	-5.7%

💧 Cash Flow (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Cash from Operating Activity	1.30	6.21	17.07	7.28	-57.4%
Cash from Investing Activity	-0.18	-7.92	-11.61	-2.41	+79.2%
Cash from Financing Activity	-1.05	2.06	-5.93	-4.89	+17.5%
Net Cash Flow	0.07	0.35	-0.47	-0.02	+95.7%
Free Cash Flow	1.14	-1.49	5.60	5.05	-9.8%
CFO/OP	42%	129%	270%	144%	-46.7%

➗ Ratios (latest 4 periods)

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	% Chg
Debtor Days	142.71	134.05	125.56	123.93	-1.3%
Inventory Days	677.26	909.72	921.61	791.32	-14.1%
Days Payable	222.42	207.75	151.98	145.61	-4.2%
Cash Conversion Cycle	597.56	836.02	895.19	769.64	-14.0%
Working Capital Days	207.73	226.67	210.99	191.58	-9.2%
ROCE %	8.03%	8.07%	3.94%	2.52%	-36.0%

👥 Shareholding (latest 4 periods)

Metric	Sep 2025	Dec 2025	Mar 2026	Jun 2026	% Chg
Promoters	46.89%	46.89%	46.89%	46.89%	+0.0%
Public	53.11%	53.11%	53.11%	53.11%	+0.0%
No. of Shareholders	1,193	1,200	1,182	1,165	-1.4%

⚖️ Peer comparison

Industry: Medical Equipment & Supplies · 13 companies · full page →

#	Company	CMP	MCap (Cr)	P/E	Sales TTM	NP TTM	OPM%	NPM%	Sales YoY%	NP YoY%	Qtr Rev Δ%	Qtr NP Δ%
1	FISCHER Fischer Medical	₹33.50	2,293	85.2	367	24	12.3%	6.7%	178.6%	2051.4%	249.4%	-24.3%
2	TARSONS Tarsons Products	₹330.00	1,756	157.9	441	11	27.0%	2.5%	-66.3%	-81.4%	20.7%	-181.0%
3	DENTALKART Vasa Denticity	₹563.10	977	80.0	299	12	4.4%	4.0%	16.7%	-28.5%	12.9%	-2.9%
4	543916 Hemant Surgical	₹193.85	544	13.9	231	18	10.4%	7.8%	—	—	187.9%	160.0%
5	543363 Prevest Denpro	₹616.50	456	32.8	75	23	35.7%	29.9%	13.6%	17.6%	23.7%	24.8%
6	QMSMEDI QMS Medical	₹185.89	359	52.7	162	7	13.1%	4.1%	5.1%	-47.9%	23.7%	-0.8%
7	NURECA Nureca	₹331.55	331	75.9	153	4	2.7%	2.8%	34.0%	146.7%	18.0%	277.2%
8	530427 Choksi Asia	₹65.64	122	7.2	47	5	14.5%	11.1%	61.1%	173.2%	-22.5%	-10.1%
9	527005 Shree Pacetronix	₹168.25	55	19.2	21	3	24.8%	15.3%	28.7%	324.3%	-8.3%	14.5%
10	544143 Royal Sense	₹139.00	47	24.7	38	3	12.8%	8.0%	—	—	2.5%	-5.4%
11	533212 GKB Ophthalmics	₹104.90	32	17.6	150	6	7.0%	3.7%	36.8%	142.7%	2.3%	388.5%
12	531380 Centenial Surgical	₹110.90	27	—	56	-1	10.7%	-2.6%	0.6%	-38.1%	18.6%	1937.8%
13	542765 Transpact Enterprises	₹325.00	4	140.1	0	0	63.2%	47.4%	—	—	12.5%	-20.0%

❓ Frequently asked questions

What was Centenial Surgical Suture Ltd's revenue in Q1 FY27?

What was Centenial Surgical Suture Ltd's net profit in Q1 FY27?